Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05471011 · ClinicalTrials.gov registry record

COVID-19 Outcome Prediction Algorithm

A clinical trial of COVID-19 and Long COVID, sponsored by University of California, Los Angeles.

Recruiting
Registry status
600
Enrollment target
7
Study locations

NCT05471011 is a study of COVID-19 and Long COVID that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 600 participants, below the 55,212-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 7 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05471011, a study of COVID-19 and Long COVID, is actively recruiting participants, sponsored by University of California, Los Angeles.

RECRUITING
Registry status
600 participants
Enrollment target
7
Study locations

Study Summary

Severe acute respiratory syndrome coronavirus 2-mediated coronavirus disease (COVID-19) is an evolutionarily unprecedented natural experiment that causes major changes to the host immune system. We propose to develop a test that accurately predicts short- and long-term (within one-year) outcomes in hospitalized COVID-19 patients broadly reflecting US demographics who are at increased risk of adverse outcomes from COVID-19 using both clinical and molecular data. We will enroll patients from a hospitalized civilian population in one of the country's largest metropolitan areas and a representative National Veteran's population.

Conditions Studied

COVID-19 Long COVID Post Acute Sequelae of COVID-19 Frailty Syndrome Organ Dysfunction Syndrome, Multiple

Interventions

  • OTHER Blood and nasal swab sampling

Study Locations (7)

California

  • VA Greater Los Angeles Healthcare System - Los Angeles
  • Ronald Reagan UCLA Medical Center - Los Angeles
  • Olive View-UCLA Education & Research Institute - Sylmar
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center - Torrance

Georgia

  • Atlanta VA Medical Center - Decatur

New York

  • Bronx VA Medical Center - The Bronx

Texas

  • Michael E. DeBakey VA Medical Center - Houston

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2022-08-08
Est. Completion 2026-05-31

Sponsor

University of California, Los Angeles

897 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05471011

The ClinicalTrials.gov registry entry for NCT05471011 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,212-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which Blood and nasal swab sampling is the first listed.

NCT05471011 reports 7 study locations spanning 4 distinct geographic areas - top geographies include California, Georgia, New York.

Frequently Asked Questions

What is clinical trial NCT05471011 about?

NCT05471011 is a clinical study titled "COVID-19 Outcome Prediction Algorithm". Severe acute respiratory syndrome coronavirus 2-mediated coronavirus disease (COVID-19) is an evolutionarily unprecedented natural experiment that causes major changes to the host immune system. We propose to develop a test that accurately predicts short- and long-term (within one-year) outcomes in ...

What is the current status of trial NCT05471011?

This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2022-08-08. Estimated completion is 2026-05-31.

What conditions does trial NCT05471011 study?

This clinical trial studies the following conditions: COVID-19, Long COVID, Post Acute Sequelae of COVID-19, Frailty Syndrome, Organ Dysfunction Syndrome, Multiple.

What interventions are being tested in trial NCT05471011?

The interventions under investigation include: Blood and nasal swab sampling (OTHER).

Who is sponsoring clinical trial NCT05471011?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05471011 being conducted?

This trial has 7 study locations across California, Georgia, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

COVID-19

All registered trials for this condition

Long COVID

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.